Overview
Sibel Gultekin practices practicing medicine in Gazi, Turkey.
Ms. Gultekin is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Oral Cancer, Bone Tumor, Head and Neck Squamous Cell Carcinoma (HNSCC), and PIK3CA-Related Overgrowth Spectrum.
She is actively involved in clinical research, co-authoring 33 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sibel E. Gultekin
Is Sibel E. Gultekin a top-rated expert for Oral Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Sibel E. Gultekin is classified as an Distinguished expert for Oral Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sibel E. Gultekin participate in research or clinical trials?
Yes. Sibel E. Gultekin has published 33 articles and abstracts on conditions like Oral Cancer. You can view a list of Sibel E. Gultekin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Oral CancerMs. Gultekin isDistinguished. Learn about Oral Cancer.
- Experienced
- Bone TumorMs. Gultekin isExperienced. Learn about Bone Tumor.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- PIK3CA-Related Overgrowth SpectrumMs. Gultekin isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.